Orexigen Drops After Report Questions Drug Data Reliability
March 05, 2015 at 18:25 PM EST
Shares of Orexigen Therapeutics Inc. dropped in the extended session Thursday following a report alleging data for the biotech's obesity treatment might be unreliable.
